IMAC Holdings Future Growth

Future criteria checks 0/6

IMAC Holdings is forecast to grow earnings at 17.9% per annum. EPS is expected to grow by 18.4% per annum.

Key information

17.9%

Earnings growth rate

18.4%

EPS growth rate

Healthcare earnings growth	17.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	Low
Last updated	24 Apr 2024

Recent future growth updates

Recent updates

IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry

Apr 18

Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way?

Oct 12

IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount

Jun 14

Earnings and Revenue Growth Forecasts

NasdaqCM:BACK - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	N/A	-4	N/A	-4	1
12/31/2024	N/A	-4	N/A	-5	1
3/31/2024	N/A	-6	-2	-2	N/A
12/31/2023	N/A	-6	-3	-3	N/A
9/30/2023	8	-15	-5	-5	N/A
6/30/2023	11	-18	-6	-6	N/A
3/31/2023	14	-19	-9	-9	N/A
12/31/2022	N/A	-12	-11	-10	N/A
9/30/2022	17	-14	-10	-10	N/A
6/30/2022	17	-11	-10	-9	N/A
3/31/2022	15	-11	-9	-8	N/A
12/31/2021	14	-11	-8	-8	N/A
9/30/2021	13	-8	-8	-8	N/A
6/30/2021	13	-7	-8	-7	N/A
3/31/2021	13	-6	-7	-7	N/A
12/31/2020	13	-6	-6	-6	N/A
9/30/2020	14	-7	-6	-5	N/A
6/30/2020	14	-7	-6	-5	N/A
3/31/2020	16	-7	-5	-4	N/A
12/31/2019	15	-6	-5	-4	N/A
9/30/2019	14	-6	-3	-3	N/A
6/30/2019	12	-5	-2	-3	N/A
3/31/2019	9	-4	-3	-2	N/A
12/31/2018	7	-3	-3	-2	N/A
9/30/2018	4	-2	-4	-2	N/A
6/30/2018	2	-1	-3	-1	N/A
3/31/2018	1	-1	-2	-1	N/A
12/31/2017	1	0	N/A	0	N/A
12/31/2016	0	0	N/A	-1	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BACK is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BACK is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BACK is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if BACK's revenue is forecast to grow faster than the US market.

High Growth Revenue: BACK is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if BACK's Return on Equity is forecast to be high in 3 years time

IMAC Holdings Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target decreased by 17% to US$1.25

Consensus forecasts updated

Price target decreased to US$5.00

Consensus estimates of losses per share improve by 10%

Price target decreased to US$5.50

Consensus EPS estimates fall to -US$0.38

Recent updates

Theralink Technologies, Inc. (OTCPK:THER) cancelled the acquisition of IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.

IMAC Holdings, Inc. announced delayed annual 10-K filing

Insufficient new directors

IMAC Holdings, Inc. Announces Executive Changes

IMAC Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement of $2.5 Million for Continued Listing on the Nasdaq Capital Market Under Listing Rule 5550(b)(1)

IMAC Holdings, Inc. announced delayed 10-Q filing

Insufficient new directors

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

IMAC Holdings, Inc. Receive Non-Compliance Letter from Nasdaq

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split to Regain Compliance

Price target decreased by 17% to US$1.25

IMAC Holdings Provides Nasdaq Compliance Update Regarding Minimum Stockholders' Equity Requirement and Minimum Bid Price Requirement

IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors

IMAC Holdings, Inc., Annual General Meeting, Jul 05, 2023

IMAC Holdings Receives A Non-Compliance Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Theralink Technologies, Inc. (OTCPK:THER) entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$5.00

IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line

IMAC Holdings Receives Notice from The Nasdaq Stock Market Regarding Minimum Bid Price Requirement

IMAC Holdings, Inc. Announces Completion of Third Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Consensus estimates of losses per share improve by 10%

IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

IMAC Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $3.925 million.

IMAC Holdings, Inc. Adds Stretch Services At the Backspace

Price target decreased to US$5.50

IMAC Holdings, Inc. Announces the Launch of Spinal Health and Wellness Products and Supplements

IMAC Holdings, Inc., Annual General Meeting, Jul 06, 2022

IMAC Holdings, Inc. announced delayed annual 10-K filing

IMAC Holdings, Inc. Announces Completion of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’S Disease

IMAC Holdings, Inc. Announces Executive Changes

Imac Holdings, Inc. Announces Relocates of Growing Clinic in St. Louis Area

Third quarter 2021 earnings released: US$0.068 loss per share (vs US$0.12 loss in 3Q 2020)

Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way?

Consensus EPS estimates fall to -US$0.38

Price target decreased to US$3.50

Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.20 loss in 2Q 2020)

IMAC Holdings, Inc. Announces Initiation of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings Launches Acute Care Services for Musculoskeletal Injuries

IMAC Holdings, Inc. (NasdaqCM:IMAC) agreed to acquire Active Medical Center Ltd.

IMAC Holdings, Inc. (NasdaqCM:IMAC) acquired Fort Pierce Chiropractic.

IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount

Imac Holdings, Inc. Introduces the Back Space - First In-Store Chiropractic and Spinal Care Location Within Walmart

Consensus EPS estimates increase to -US$0.34

Consensus revenue estimates fall to US$14.3m

First quarter 2021 earnings released: US$0.15 loss per share (vs US$0.18 loss in 1Q 2020)

Analysts increase EPS estimates to -US$0.36

We Think IMAC Holdings (NASDAQ:IMAC) Has A Fair Chunk Of Debt

Full year 2020 earnings released: US$0.45 loss per share (vs US$0.84 loss in FY 2019)

Revenue and earnings miss expectations

IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings, Inc. Partners with Fortune 500 Company to Launch In-Store Spinal Care

IMAC Holdings, Inc. Adds Regenerative Wound Care Service in Regeneration Centers

New 90-day high: US$1.98

IMAC Holdings, Inc. (NasdaqCM:IMAC) entered into an asset purchase agreement to acquire assets from Willmitch Chiropractic.

IMAC expands Florida presence with Tampa clinic acquisition

New 90-day high: US$1.95

IMAC Holdings, Inc. (NasdaqCM:IMAC) executed a definitive agreement to acquire assets of NCH Chiropractic, PLLC.

IMAC acquires Synergy Healthcare, expanding Florida presence

IMAC Holdings, Inc. Appoints Sheri Gardzina as Chief Financial Officer

New 90-day high: US$1.53

IMAC Holdings, Inc. Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’S Disease

IMAC completes first infusion of stem cells in parkinson’s disease study

IMAC Holdings receives $1.69M PPP loan waiver

IMAC Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement